Skip to content

T-wave Alternans and Intrathoracic Impedance Measurements

T-wave Alternans and Intrathoracic Impedance Measurements

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00669682
Enrollment
9
Registered
2008-04-30
Start date
2008-08-31
Completion date
2012-04-30
Last updated
2013-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Congestive Heart Failure

Brief summary

T-wave alternans is a test that is currently being used to risk stratify patients with structural heart disease for sudden cardiac death. The mechanism of T-wave alternans is unclear, but may share a common abnormality with conditions of cardiac fluid overload such as heart failure, which is altered intracellular calcium handling. Current Medtronic implantable defibrillators have the capability of monitoring cardiac fluid status via transthoracic impedance measurements. The purpose of this study is to determine if a correlation exists between T-wave alternans status and cardiac volume status, as determined by transthoracic impedance measurements. Secondarily, the study seeks to examine the relationship between arrhythmia frequency and T-wave alternans or cardiac volume status.

Interventions

OTHERCongestive heart failure

Spontaneous occurrence of fluid overload.

Sponsors

Medtronic
CollaboratorINDUSTRY
Columbia University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Class III or IV heart failure patients with a chronically implanted Medtronic biventricular defibrillator system capable of monitoring intrathoracic fluid volume.

Exclusion criteria

* no active ischemia or pulmonary edema, atrial fibrillation, complete heart block

Design outcomes

Primary

MeasureTime frameDescription
Number of Positive Twave Studies and Concurrent Positive Optivol Measurementupto 3 yearsWe wanted to examine whether positive Optivol status corresponded to a higher likelihood of a positive T wave study. The T wave alternans result is determined by a proprietary device that measures T wave and reports the result as negative, positive, or indeterminate. The Optivol measurement is obtained through transthoracic impedance values in the implanted device. We investigated the correlation between Optivol status and T wave alternans status.

Countries

United States

Participant flow

Recruitment details

9 patients enrolled from device clinic between 8/14/08 and 2/11/11

Participants by arm

ArmCount
Group A
The study group will include Class III to IV heart failure patients followed in the device clinic that have a chronically implanted (more than 90 days) Medtronic biventricular defibrillator with the ability to monitor intrathoracic impedance.
9
Total9

Baseline characteristics

CharacteristicGroup A
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
2 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
Age Continuous60 years
STANDARD_DEVIATION 10
Region of Enrollment
United States
9 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 9
serious
Total, serious adverse events
0 / 9

Outcome results

Primary

Number of Positive Twave Studies and Concurrent Positive Optivol Measurement

We wanted to examine whether positive Optivol status corresponded to a higher likelihood of a positive T wave study. The T wave alternans result is determined by a proprietary device that measures T wave and reports the result as negative, positive, or indeterminate. The Optivol measurement is obtained through transthoracic impedance values in the implanted device. We investigated the correlation between Optivol status and T wave alternans status.

Time frame: upto 3 years

ArmMeasureGroupValue (NUMBER)
Positive Optivol StatusNumber of Positive Twave Studies and Concurrent Positive Optivol MeasurementPositive T wave alternans1 participants
Positive Optivol StatusNumber of Positive Twave Studies and Concurrent Positive Optivol MeasurementNegative T wave alternans2 participants
Negative Optivol StatusNumber of Positive Twave Studies and Concurrent Positive Optivol MeasurementPositive T wave alternans1 participants
Negative Optivol StatusNumber of Positive Twave Studies and Concurrent Positive Optivol MeasurementNegative T wave alternans5 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026